Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis

被引：19
|
作者：
Younus, J. [1 ]
Vandenberg, T. [1 ]
Jawaid, M. [2 ]
Jawaid, M. A. [3 ]
机构：
[1] London Reg Canc Program, Dept Med Oncol, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, Schulich Sch Med, London, ON, Canada
[3] Univ Western Ontario, Dept Social Sci, London, ON, Canada
来源：
CURRENT ONCOLOGY | 2012年 / 19卷 / 06期
关键词：
Febrile neutropenia; breast cancer; adjuvant chemotherapy; RANDOMIZED-TRIALS; METAANALYSIS; DOXORUBICIN; OUTCOMES; OLDER;
D O I：
10.3747/co.19.1174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：332 / 334
页数：3
相关论文
共 50 条
  • [21] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Kimura, Yuri
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3507 - 3512
  • [22] Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review
    Ricardo Fernandes
    Sasha Mazzarello
    Carol Stober
    Lisa Vandermeer
    Shaan Dudani
    Mohamed F. K. Ibrahim
    Habeeb Majeed
    Kirstin Perdrizet
    Risa Shorr
    Brian Hutton
    Dean Fergusson
    Mark Clemons
    Breast Cancer Research and Treatment, 2017, 161 : 1 - 10
  • [23] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Yuri Kimura
    Shinsuke Sasada
    Akiko Emi
    Norio Masumoto
    Takayuki Kadoya
    Morihito Okada
    Supportive Care in Cancer, 2021, 29 : 3507 - 3512
  • [24] Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review
    Fernandes, Ricardo
    Mazzarello, Sasha
    Stober, Carol
    Vandermeer, Lisa
    Dudani, Shaan
    Ibrahim, Mohamed F. K.
    Majeed, Habeeb
    Perdrizet, Kirstin
    Shorr, Risa
    Hutton, Brian
    Fergusson, Dean
    Clemons, Mark
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 1 - 10
  • [25] The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the adjuvant docetaxel and cyclophosphamide in patients with early-stage breast cancer: A meta-analysis.
    Tran Do
    Niravath, Polly Ann
    Trivedi, Meghana
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Clinical impact of febrile neutropenia (FIN) increase among patients receiving adjuvant docetaxel/cyclophosphamide (TC) chemotherapy compared to TC plus pegfilgrastim for breast cancer
    Hamilton, Erika Paige
    Topping, Donna L.
    Peppercorn, Jeffrey M.
    Marcom, P. Kelly
    Kimmick, Gretchen Genevieve
    Duff, Erin
    Cirrincione, Constance T.
    Blackwell, Kimberly L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] RATE OF FEBRILE NEUTROPENIA WITH DOCETAXEL/CYCLOPHOSPHAMIDE (TC) IN WOMEN WITH EARLY STAGE BREAST CANCER: AN AUSTRALIAN PUBLIC HOSPITAL EXPERIENCE
    Pokharel, K.
    Lovat, K.
    Chern, B.
    Bigby, K.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 42 - 42
  • [28] Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
    Kim, Chang Gon
    Sohn, Joohyuk
    Chon, Hongjae
    Kim, Joo Hoon
    Heo, Su Jin
    Cho, Hyunsoo
    Kim, In Jung
    Kim, Seung Il
    Park, Seho
    Park, Hyung Seok
    Kim, Gun Min
    JOURNAL OF BREAST CANCER, 2016, 19 (01) : 76 - 82
  • [29] Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer
    Hajime Abe
    Tsuyoshi Mori
    Yuki Kawai
    Hirotomi Cho
    Yoshihiro Kubota
    Tomoko Umeda
    Yoshimasa Kurumi
    Tohru Tani
    International Journal of Clinical Oncology, 2013, 18 : 487 - 491
  • [30] Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer
    Abe, Hajime
    Mori, Tsuyoshi
    Kawai, Yuki
    Cho, Hirotomi
    Kubota, Yoshihiro
    Umeda, Tomoko
    Kurumi, Yoshimasa
    Tani, Tohru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 487 - 491
12345